WASHINGTON -- PharmedOut announces its fourth annual conference, "Medical Behavior in a Commercial World: Who is Responsible?" focusing on the responsibilities of health care providers, journals, industry and others in ensuring that patients receive the best treatments.
What: Presentations, panels and discussions on accountability within the health care system and marketing influences on patient care. Speakers include:
- Marcia Angell, MD, former editor-in-chief, New England Journal of Medicine; author, "The Truth About Drug Companies;" senior lecturer at Harvard Medical School
- Michael Kafrissen, MD, MPH, research scientist, MIT AgeLab, and former pharmaceutical executive
- Stephen Braun, freelance medical writer and ghostwriter
- Carl Elliott MD, PhD, author, "White Coat, Black Hat" and "Better Than Well;" professor, Center for Bioethics, professor, departments of pediatrics and philosophy, University of Minnesota
- Virginia Barbour, MD, chief editor, PLOS Medicine
- Charles Ornstein, senior reporter, ProPublica; president, Association of Health Care Journalists
- Diana Zuckerman, PhD, president, National Research Center for Women and Families
- Daniel Carlat, MD, director, Pew Prescription Project
Topics will include opioid overuse, medical devices, ghostwriting, the Physician Payments Sunshine Act and pharmacist-industry relationships. The full agenda is available at pharmedout.org.
When: Thursday, June 6, and Friday, June 7, 2013, 8:30 a.m. to 5:30 p.m.
Where: Lohrfink Auditorium in the Hariri Building, Georgetown University, 37th and O Streets, NW, Washington, DC, 20057.
Complimentary registration is available for credentialed journalists by contacting Karen Mallet at firstname.lastname@example.org.
Funding for the conference is provided by Georgetown University Medical Center, the Southern Network on Adverse Reactions and individual donations.
PharmedOut is a project of volunteer health professionals and students who promote evidence-based prescribing, educate health care professionals about pharmaceutical marketing practices, and provide access to unbiased information about medications. The project is led by Adriane Fugh-Berman, MD, associate professor of pharmacology and physiology at Georgetown University Medical Center.